BMO Capital Starts Ra Pharma (RARX) at Outperform

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. ZS
2. MRVL
3. PENG
4. STZ
5. CRBU
6. SKYD
7. BBIO
8. NEOG
9. FIGR
10. INTC

Go back to BMO Capital Starts Ra Pharma (RARX) at Outperform

Credit Suisse Starts Ra Pharma (RARX) at Outperform

November 21, 2016 6:57 AM EST

Credit Suisse initiates coverage on Ra Pharma (NASDAQ: RARX) with a Outperform rating and a price target of $19.00.

Analyst Kennen MacKay commented, "We view RA101495 as an attractive drug candidate for patients with paroxysmal nocturnal hemoglobinuria (PNH) with potential to capture >30% market... More

Jefferies Starts Ra Pharma (RARX) at Buy

November 21, 2016 6:51 AM EST

Jefferies initiates coverage on Ra Pharma (NASDAQ: RARX) with a Buy rating and a price target of $25.00.

Analyst Eun Yang commented, "Utilizing its peptide chemistry platform, RARX focus on complement-mediated diseases. Given well-validated C5 target & encouraging Ph1 data, we view lead candidate... More